Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

ENTXENTX
4 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in ENTERA BIO LTD

Yes. JPMorgan Chase holds 40,883 shares of ENTX (Entera Bio), worth $67,457, as of its Q2 2026 13F filing. It increased the position from 7,150 shares in Q1 2026. JPMorgan Chase has held ENTX since Q1 2026, across 2 quarterly 13F filings.

Current Value

$67,457

Current Shares

40,883

Total Value Change

+$67,453

Total Shares Change

+40,881

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
40,883
+471.8%
$67,4570.0%$1.77
23
2026-Q1
New
7,150
-
$7,1500.0%$1.11
25
2024-Q4
Exited
0
-100.0%
$00.0%$2.12
0
2024-Q3
First report
2
-
$40.0%$1.90
0

Other major holders of ENTX: RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used